Developer docs
API playgroundTry for free, no card

Search company profiles

CannTrust

Full company profile

uuid000623a

Namestring
CannTrust
Websiteurl
canntrust.ca
Company typeenum
Public
Founded yearint
2014
Descriptiontext

CannTrust is a Canadian licensed cannabis producer founded in 2014 and headquartered in Toronto, Canada. The company cultivates, produces, and sells cannabis products for both medical and recreational consumers within Canada's legal cannabis framework established under the Cannabis Act. CannTrust generates revenue primarily through cannabis product sales in the legal Canadian market, operating as one of the licensed producers competing in a regulated industry with limited unlicensed competition.

The company is publicly traded, listing on the Canadian Securities Exchange under the ticker TRST and on the OTCMKTS under CNTTF. CannTrust has raised over $127 million across multiple funding rounds since 2014, with the majority concentrated in 2017 and 2018 during the Canadian cannabis sector expansion. Kenzoll's Marshall Fields has served as a recurring financial partner across funding rounds, including a 2022 capital infusion of approximately $4.3 million. The company maintains a headcount of 101-250 employees based in Toronto.

CannTrust's leadership has experienced turnover, with co-founder Norman Paul serving as a director while the CEO role has transitioned from Greg Guyatt to interim CEO Robert Marcovitch. Brad Rogers holds the President and COO position and Randy Daigneau serves as VP of Operations. The reported financials show significant volatility, with operating income swinging from positive to deeply negative across reporting periods, raising concerns about operational sustainability. CannTrust does not publicly disclose detailed product line information, pricing, or customer segmentation in available source data, limiting visibility into commercial specifics.

Short descriptiontext

CannTrust is a Toronto-based, publicly traded Canadian licensed cannabis producer founded in 2014 that cultivates and sells medical and recreational cannabis products to consumers within Canada's regulated legal cannabis market.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
cannabis products, medical cannabis, recreational cannabis, cannabis cultivation, cannabis distribution
Industry1 code
1Dual-License Cannabis Dispensaries (Adult-Use + Medical)
CodeCRANAFACPrimaryYes
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Pharmaceutical Preparations2834
Product category
Cannabis Products
Revenue model1 record
1Cannabis Product Sales
TypeHardware Sales
Description

CannTrust operates as a cannabis producer, generating revenue through the cultivation, production, and sale of cannabis products to consumers in the legal cannabis market.

pehub.com
Cost components3 values
Supply Chain, Operations, Personnel
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

CannTrust is a Canadian licensed producer of medical and recreational cannabis. The company cultivates, processes, and distributes cannabis products to consumers and patients, including dried flower, oils, capsules, and other cannabis-derived formats.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

CannTrust is a cannabis producer. The company is publicly traded on the OTCMKTS exchange under the ticker symbol CNTTF. No specific product details, brand names, or service offerings are available in the source data.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Canadian cannabis producer with medical, wellness, and adult-use offerings, plus clinic network. Comparable to CannTrust in combining medical and recreational channels under Canadian licensure.

TypeDirect peer
Description

Canadian licensed producer focused on dried flower, pre-rolls, vapes, and edibles. Comparable mid-cap LP directly competing with CannTrust in the Canadian recreational and medical markets.

TypeBroad incumbent
Description

Canadian cannabis producer with cultivation, processing, and consumer product lines. Comparable to CannTrust as a publicly traded Canadian LP with overlapping product categories.

TypeDirect peer
Description

Vertically integrated Canadian cannabis producer leveraging greenhouse cultivation expertise. Comparable to CannTrust as a Canadian LP with cultivation-led operations and public listing.

TypeDirect peer
Description

One of Canada's largest federally licensed cannabis producers operating across medical, recreational, and international markets. Directly comparable to CannTrust as a Canadian LP with multi-product portfolios and public listing.

TypeDirect peer
Description

Canadian licensed cannabis producer with cultivation, processing, and medical/recreational distribution. Direct peer to CannTrust in scale, regulatory framework, and product breadth.

TypeDirect peer
Description

Canadian licensed producer of premium cannabis flower, pre-rolls, and concentrates. Comparable to CannTrust as a smaller Canadian LP competing in the recreational market.

TypeDirect peer
Description

Canadian cannabis company with branded consumer products and licensed cultivation assets. Comparable to CannTrust as a small-cap Canadian LP with multi-format product strategy.

TypeDirect peer
Description

Canadian licensed cannabis producer with branded recreational and medical offerings. Comparable to CannTrust in regulatory positioning, public listing, and product mix.

TypeDirect peer
Description

Canadian-headquartered global cannabis producer with medical and consumer-facing brands. Comparable to CannTrust as a federally licensed Canadian producer pursuing international and medical channels.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CannTrust

Cannabis Productscanntrust.ca

CannTrust is a Toronto-based, publicly traded Canadian licensed cannabis producer founded in 2014 that cultivates and sells medical and recreational cannabis products to consumers within Canada's regulated legal cannabis market.

What CannTrust does

CannTrust is a Canadian licensed cannabis producer founded in 2014 and headquartered in Toronto, Canada. The company cultivates, produces, and sells cannabis products for both medical and recreational consumers within Canada's legal cannabis framework established under the Cannabis Act. CannTrust generates revenue primarily through cannabis product sales in the legal Canadian market, operating as one of the licensed producers competing in a regulated industry with limited unlicensed competition.

The company is publicly traded, listing on the Canadian Securities Exchange under the ticker TRST and on the OTCMKTS under CNTTF. CannTrust has raised over $127 million across multiple funding rounds since 2014, with the majority concentrated in 2017 and 2018 during the Canadian cannabis sector expansion. Kenzoll's Marshall Fields has served as a recurring financial partner across funding rounds, including a 2022 capital infusion of approximately $4.3 million. The company maintains a headcount of 101-250 employees based in Toronto.

CannTrust's leadership has experienced turnover, with co-founder Norman Paul serving as a director while the CEO role has transitioned from Greg Guyatt to interim CEO Robert Marcovitch. Brad Rogers holds the President and COO position and Randy Daigneau serves as VP of Operations. The reported financials show significant volatility, with operating income swinging from positive to deeply negative across reporting periods, raising concerns about operational sustainability. CannTrust does not publicly disclose detailed product line information, pricing, or customer segmentation in available source data, limiting visibility into commercial specifics.

CannTrust firmographics

Firmographics
Name
CannTrust
Website
https://canntrust.ca
Company type
Public
Founded year
2014
Operating status
Operating
Headcount range
101–250 employees
Short description
CannTrust is a Toronto-based, publicly traded Canadian licensed cannabis producer founded in 2014 that cultivates and sells medical and recreational cannabis products to consumers within Canada's regulated legal cannabis market.
Ownership category
akta.pro rank

CannTrust industry classification

Industry
Product category
Cannabis Products
NAICS
Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)
akta.pro primary industry
Dual-License Cannabis Dispensaries (Adult-Use + Medical) (CRANAFAC)

Keywords

  • Cannabis products
  • Medical cannabis
  • Recreational cannabis
  • Cannabis cultivation
  • Cannabis distribution

Where CannTrust is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Markets served

CannTrust business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel

Revenue model

  1. Cannabis Product Sales: CannTrust operates as a cannabis producer, generating revenue through the cultivation, production, and sale of cannabis products to consumers in the legal cannabis market.

CannTrust product offering

Product offering

Core offering

CannTrust is a Canadian licensed producer of medical and recreational cannabis. The company cultivates, processes, and distributes cannabis products to consumers and patients, including dried flower, oils, capsules, and other cannabis-derived formats.

Product overview

CannTrust is a cannabis producer. The company is publicly traded on the OTCMKTS exchange under the ticker symbol CNTTF. No specific product details, brand names, or service offerings are available in the source data.

Differentiator

Problem solved

Functional benefit

Companies that use CannTrust

Customer profile

Ideal customer profiles1 record

CannTrust technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

CannTrust partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves5 records

Expansion highlights3 records

CannTrust competitors and assessment

Company assessment

Direct peers

  • Aleafia Health: Canadian cannabis producer with medical, wellness, and adult-use offerings, plus clinic network. Comparable to CannTrust in combining medical and recreational channels under Canadian licensure.
  • OrganiGram Holdings: Canadian licensed producer focused on dried flower, pre-rolls, vapes, and edibles. Comparable mid-cap LP directly competing with CannTrust in the Canadian recreational and medical markets.
  • Village Farms International: Vertically integrated Canadian cannabis producer leveraging greenhouse cultivation expertise. Comparable to CannTrust as a Canadian LP with cultivation-led operations and public listing.
  • Canopy Growth Corporation: One of Canada's largest federally licensed cannabis producers operating across medical, recreational, and international markets. Directly comparable to CannTrust as a Canadian LP with multi-product portfolios and public listing.
  • Aurora Cannabis: Canadian licensed cannabis producer with cultivation, processing, and medical/recreational distribution. Direct peer to CannTrust in scale, regulatory framework, and product breadth.
  • Decibel Cannabis Company: Canadian licensed producer of premium cannabis flower, pre-rolls, and concentrates. Comparable to CannTrust as a smaller Canadian LP competing in the recreational market.
  • Auxly Cannabis Group: Canadian cannabis company with branded consumer products and licensed cultivation assets. Comparable to CannTrust as a small-cap Canadian LP with multi-format product strategy.
  • Cronos Group: Canadian licensed cannabis producer with branded recreational and medical offerings. Comparable to CannTrust in regulatory positioning, public listing, and product mix.
  • Tilray Brands: Canadian-headquartered global cannabis producer with medical and consumer-facing brands. Comparable to CannTrust as a federally licensed Canadian producer pursuing international and medical channels.

Broad incumbents

  • Sundial Growers: Canadian cannabis producer with cultivation, processing, and consumer product lines. Comparable to CannTrust as a publicly traded Canadian LP with overlapping product categories.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat2 records

Key risks6 records

Key highlights6 records

Customer concentration

CannTrust social profiles

Digital presence

CannTrust financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CannTrust leadership team

Management profile

Number of profiles

CannTrust funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CannTrust M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CannTrust

What does CannTrust do?

CannTrust is a Canadian licensed producer of medical and recreational cannabis. The company cultivates, processes, and distributes cannabis products to consumers and patients, including dried flower, oils, capsules, and other cannabis-derived formats.

Is CannTrust a public or private company?

CannTrust is a public company. It is classified as public and is currently operating.

When was CannTrust founded?

CannTrust was founded in 2014. It employs 101 to 250 people.

Where is CannTrust based?

CannTrust is headquartered in Toronto, Canada, in the North America region.

How does CannTrust make money?

One revenue line is on record: cannabis Product Sales.

Who are CannTrust's main competitors?

Direct peers on record are Aleafia Health, OrganiGram Holdings, Village Farms International, Canopy Growth Corporation, Aurora Cannabis, Decibel Cannabis Company, Auxly Cannabis Group, Cronos Group and Tilray Brands. Sundial Growers is listed as a broad incumbent.

Does CannTrust have an API?

No public API is recorded for CannTrust.

What industry is CannTrust in?

CannTrust's product category is Cannabis Products. Its primary akta.pro industry code is CRANAFAC, Dual-License Cannabis Dispensaries (Adult-Use + Medical). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Defense WorldReviewing CannTrust (OTCMKTS:CNTTF) & Nuvo Pharmaceuticals (OTCMKTS:MRVFF)This article presents a comparative analysis of CannTrust Holdings Inc. and Nuvo Pharmaceuticals Inc., two Canadian pharmaceutical companies, examining metrics including revenue, earnings, valuation ratios, volatility, and profitability. CannTrust shows higher earnings ($7.39 million vs -$25.70 million) but lower revenue ($15.96 million vs $54.98 million), while Nuvo Pharmaceuticals trades at a lower price-to-earnings ratio and demonstrates lower stock volatility (beta of 0.98 vs 4.52). The analysis concludes that CannTrust outperforms Nuvo Pharmaceuticals on 6 of 10 factors compared between the two stocks.Defense WorldAnalyzing ASLAN Pharmaceuticals (NASDAQ:ASLN) & CannTrust (OTCMKTS:CNTTF)This article presents a comparative financial analysis of two pharmaceutical companies: ASLAN Pharmaceuticals, a clinical-stage immunology-focused biopharmaceutical company headquartered in Singapore, and CannTrust Holdings, a Canadian medical cannabis producer based in Vaughan. The analysis compares multiple metrics including gross revenue (CannTrust at $15.96 million vs. ASLAN at $12 million), earnings per share, valuation ratios, institutional ownership, and stock volatility (beta). The article concludes that CannTrust outperforms ASLAN on 7 of 9 compared factors, while ASLAN trades at a lower price-to-earnings ratio making it the more affordable of the two stocks.PR NewswireCannTrust Holdings Inc. Makes Proposal under the Bankruptcy and Insolvency ActCannTrust Holdings Inc. announced it has made a Division I Proposal under Canada's Bankruptcy and Insolvency Act, determining it is not feasible to complete the audit required to hold an annual general meeting by November 30, 2022. The proposal is being funded by Phoena Holdings Inc. with support from Marshall Fields Holdings, Phoena's largest shareholder and a subsidiary of Netherlands-based private-equity company Kenzoll B.V. Subject to creditor and court approval, CTH intends to address its remaining liabilities, distribute its shares in Phoena to existing shareholders holding at least 10,000 common shares, and dissolve.PR NewswireCannTrust Extends Time to Call Annual General MeetingThe Ontario Superior Court of Justice granted CannTrust Holdings Inc. an extension to hold its annual shareholder meeting until no later than November 30, 2022. The company, which is operating under Companies' Creditors Arrangement Act (CCAA) creditor protection proceedings, remains subject to a cease-trade order issued by the Ontario Securities Commission for failing to comply with securities disclosure obligations, and its shares have been delisted from both the Toronto Stock Exchange and New York Stock Exchange. CannTrust's primary asset is an approximately 10% equity interest in Phoena Holdings Inc.PR NewswireCannTrust Applies to Ontario Court to Extend Time for Annual General Meeting and Provides Update Regarding Strategic ReviewCannTrust Holdings Inc. has applied to the Ontario Superior Court of Justice for an extension to hold its annual general meeting until November 30, 2022, citing delays in finalizing audited financial statements with auditor MNP LLP. The company is simultaneously reviewing strategic alternatives, including potential listing on a Canadian stock exchange or share exchange with minority investee Phoena Holdings Inc., while remaining subject to a cease-trade order from the Ontario Securities Commission.PR NewswireCannTrust Completes CAD $17 million Financing, Exits CCAACannTrust Holdings Inc. announced that its subsidiary CannTrust Equity Inc. has completed a CAD $17 million financing, with Netherlands-based Kenzoll B.V. acquiring a 90% equity stake for CAD $11.2 million and providing a CAD $5.5 million secured credit facility. The companies comprising the CannTrust Group have emerged from their Court-supervised proceedings under the Companies' Creditors Arrangement Act (CCAA), with CannTrust retaining a 10% equity stake in the subsidiary. The company now plans to explore options for revoking its cease-trade order or obtaining a stock exchange listing within the next four months.PR NewswireCannTrust Announces New Investment Partners, Provides Timeline for CCAA ExitCannTrust Holdings Inc. announced it has secured new investment partners led by Marshall Fields International B.V., a subsidiary of Kenzoll B.V., to facilitate its exit from CCAA proceedings. The deal involves an $11.2 million private placement for approximately 90% equity in CannTrust Equity and a $5.5 million debtor-in-possession loan, with the Ontario Court of Justice approving the transaction. This strategic partnership aims to remediate past operational issues, settle litigation, and position the company for future growth in the Canadian cannabis market.PR NewswireCannTrust Announces Implementation of CCAA Plan, Settlement of Class Action Lawsuits and Board ChangesCannTrust Holdings Inc. has implemented its CCAA Plan following approvals from the Ontario Superior Court of Justice and the US District Court Southern District of New York, contributing $50 million to settle class action lawsuits and $2.7 million for CCAA proceedings claims, while four board directors resigned. Despite successfully reinstating its licenses from Health Canada and resuming operations, the company faces insufficient liquidity and is in default of its DIP loan covenant, with the DIP lender declining to waive the default while continuing to advance funds. CannTrust's CCAA proceedings are continuing to explore financing or strategic transactions, with an orderly wind-down plan being developed as a contingency, and the current stay period extends to January 31, 2022.PR NewswireCannTrust Announces Court Approval of Plan of Compromise, Arrangement and ReorganizationCannTrust Holdings Inc. announced on July 16, 2021, that its Fourth Amended & Restated Plan of Compromise, Arrangement and Reorganization was sanctioned by the Ontario Superior Court of Justice under the Companies' Creditors Arrangement Act. The company expects the plan implementation to occur within three to five months, subject to conditions including U.S. court approval and the expiration of appeal periods. CannTrust is also working with the Ontario Securities Commission to cure historical disclosure defaults and obtain a new listing for its common shares on a Canadian stock exchange.PR NewswireCannTrust Announces Court Approval for C$22.5 Million Debtor-in-Possession and CCAA Exit Credit Facility FinancingCannTrust Holdings Inc. obtained approval from the Ontario Superior Court of Justice for a C$22.5 million debtor-in-possession and CCAA Exit Credit Facility arranged by Cortland Credit Lending Corporation. The 12-month revolving facility, secured by first-ranking security over all company assets, will fund working capital needs and support restoration of operations as CannTrust continues under CCAA protection to resolve litigation and review strategic alternatives. The company remains in default of securities disclosure requirements and its securities are subject to a cease-trade order, with the credit facility being central to CannTrust's efforts to rebuild its franchise and re-enter Canadian recreational and medical cannabis markets.